The Supply Network results (ASX: SNL) were great, in FY 2022, but competitor Maxiparts (ASX: MXI) is ready to pounce.

When fear reigns it is hard to force yourself to buy growth stocks, but these three have all stood the test of time and showed their quality in good times and bad.

Catapult International results in FY 2022 were weak, and now Catapult is laying off employees. Should Catapult shareholders worry?

The Atomos results for FY 2022 were not a pretty picture, even before the auditor demanded revenue be revised lower.

The Cogstate share price is up today because of favourable clinical trial results from its partner Eisai. Why does it matter?

Netwealth market share keeps growing and I Netwealth competition faces challenges. However, keeping ahead of competition comes at a cost.

Before even thinking of buying shares in XPON Technologies, you need to understand the XPON business model.

When fear reigns it is hard to force yourself to buy growth stocks, but these are the half dozen I have most faith in (at the right price).

Mader Group has experienced stellar growth since listing in late 2019. Growth in the USA could take it to the next level.

The company initially planned to raise just $7.5m at $4.50 per share, but has increased the total due to high demand from institutions.

Baby Bunting competitors have come and gone since listing in October 2015. How has it become the leading baby retailer on the ASX?

Not only has the CEO announced his resignation but his father, the Chairman, will also be stepping aside.

PWR Holdings results, Objective
results, Alcidion results, Lovisa results and Laserbond results were all strong in FY 2022.

The Beacon Lighting results for FY22 displayed some signs of resilience in a challenging macroeconomic environment. Can Beacon continue this?

Catapult International (ASX: CAT) shareholders should be mindful of Catapult International’s competition.

The FY 2022 Diverger results show profits and dividends up about 20%, which is quite unusual for a company trading on less than 12 times EPS.

Michael Hill (ASX: MHJ) produced a polished set of results for FY 2022 as revenue and net profit after tax sparkled. But is Australia and New Zealand maturing?

The H1 FY 2022 Dicker Data results were the weakest we’ve seen in a while, largely due to factors outside the company’s control.

Lovisa (ASX: LOV) results for FY22 glisten on the back of massive growth in revenue and net profit after tax. However, is it still too expensive?

Symbio’s revenue was flat, but every profit metric was down, and $7.2m was invested in mysterious “other financial assets.”